➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Mallinckrodt
Dow
Moodys
McKesson
Colorcon

Last Updated: September 27, 2020

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR LEMBOREXANT

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Lemborexant

Trial ID Title Status Sponsor Phase Start Date Summary
NCT02583451 Study to Evaluate the Effect of Lemborexant Versus Placebo on Driving Performance in Healthy Adult and Elderly Subjects Recruiting Eisai Inc. Phase 1 2015-11-01 This is a randomized, double-blind, placebo- and active-controlled, 4-period crossover study of lemborexant in healthy adult and elderly subjects to evaluate driving performance
NCT02783729 Study of the Efficacy and Safety of Lemborexant in Subjects 55 Years and Older With Insomnia Disorder Recruiting Eisai Inc. Phase 3 2016-06-01 The primary objective of this study is to demonstrate using polysomnography (PSG) that 10 mg lemborexant is superior to zolpidem tartrate extended release 6.25 mg (Ambien CR®) on objective sleep maintenance as assessed by wake after sleep onset in the second half of the night (WASO2H) after the last 2 nights of treatment in participants 55 years and older with insomnia disorder.
NCT02952820 Long-term Study of Lemborexant in Insomnia Disorder Recruiting Eisai Inc. Phase 3 2016-10-01 The key objectives of this study are to determine, using sleep diaries, whether lemborexant at the doses 5 milligrams (mg) and 10 mg is superior to placebo on subjective sleep onset, subjective sleep efficiency, and subjective sleep maintenance in participants with insomnia disorder.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Lemborexant

Condition Name

Condition Name for Lemborexant
Intervention Trials
Healthy Subjects 4
Insomnia 2
Insomnia Disorder 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Lemborexant
Intervention Trials
Sleep Initiation and Maintenance Disorders 4
Disease 2
Sleep Apnea Syndromes 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Lemborexant

Trials by Country

Trials by Country for Lemborexant
Location Trials
United States 65
Canada 7
Germany 5
United Kingdom 4
Spain 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Lemborexant
Location Trials
Florida 7
California 5
Arizona 5
Ohio 5
New York 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Lemborexant

Clinical Trial Phase

Clinical Trial Phase for Lemborexant
Clinical Trial Phase Trials
Phase 3 3
Phase 2 1
Phase 1 8
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Lemborexant
Clinical Trial Phase Trials
Recruiting 7
Completed 3
Not yet recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Lemborexant

Sponsor Name

Sponsor Name for Lemborexant
Sponsor Trials
Eisai Inc. 12
Purdue Pharma LP 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Lemborexant
Sponsor Trials
Industry 18
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Colorcon
Dow
Baxter
Boehringer Ingelheim
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.